
PMV Pharmaceuticals PMVP
€ 1.10
-0.77%
Geschäftsbericht 2025
hinzugefügt 06.03.2026
PMV Pharmaceuticals Langfristiger Schuldenstrom 2011-2026 | PMVP
Langfristiger Schuldenstrom Jährlich PMV Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 403 K | 352 K | 852 K | 528 K | 403 K | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 852 K | 352 K | 508 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | ||
|
Amgen
AMGN
|
135 M | $ 340.0 | -0.75 % | $ 183 B | ||
|
Amneal Pharmaceuticals
AMRX
|
6.76 M | $ 12.32 | -0.24 % | $ 3.86 B | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Arcutis Biotherapeutics
ARQT
|
294 K | $ 23.27 | -1.63 % | $ 2.96 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.36 | -2.16 % | $ 362 M | ||
|
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
20.7 M | - | 0.49 % | $ 251 B | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.76 | 4.35 % | $ 9.05 B | ||
|
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.57 | -3.38 % | $ 16.1 M | ||
|
Avid Bioservices
CDMO
|
1.35 M | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
1.38 M | - | - | $ 1.41 B | ||
|
Cellectar Biosciences
CLRB
|
100 K | $ 2.75 | 1.48 % | $ 7.17 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
Concert Pharmaceuticals
CNCE
|
1.16 M | - | - | $ 401 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
CTI BioPharma Corp.
CTIC
|
781 K | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | ||
|
Cyclerion Therapeutics
CYCN
|
3.29 M | $ 3.48 | -16.14 % | $ 8.76 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.5 M | - | - | $ 2.18 B | ||
|
Dynavax Technologies Corporation
DVAX
|
4.18 M | - | - | $ 2.02 B | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Dyadic International
DYAI
|
34.6 K | $ 0.88 | 1.66 % | $ 31.8 M | ||
|
BioNTech SE
BNTX
|
45 M | $ 89.62 | -1.82 % | $ 27.2 B | ||
|
Coherus BioSciences
CHRS
|
1.83 M | $ 1.67 | - | $ 196 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
3.25 M | - | - | $ 28.6 M |